1 |
Sun W, Tang H, Gao L, et al. Mechanisms of pulmonary fibrosis induced by core fucosylation in pericytes[J]. Int J Biochem Cell Biol, 2017 (88): 44-54.
|
2 |
Hung C, Linn G, Chow YH, et al. Role of lung pericytes and resident fibroblasts in the pathogenesis of pulmonary fibrosis[J]. Am J Respir Crit Care Med, 2013, 188 (7): 820-830.
|
3 |
Wang Y, Liang Y, Luo J, et al. XIST/miR-139 axis regulates bleomycin (BLM)-induced extracellular matrix (ECM) and pulmonary fibrosis through β-catenin[J]. Oncotarget, 2017, 8 (39): 65359-65369.
|
4 |
Barron L, Gharib SA, Duffield JS. Lung pericytes and resident fibroblasts: busy multitaskers[J]. Am J Pathol, 2016, 186 (10): 2519-2531.
|
5 |
Andersson-Sjoland A, Karlsson JC, Rydell-Tormanen K. ROS-induced endothelial stress contributes to pulmonary fibrosis through pericytes and Wnt signaling[J]. Lab Invest, 2016, 96 (2): 206-217.
|
6 |
Yamaguchi Y, Takihara T, Chambers RA, et al. A peptide derived from endostatin ameliorates organ fibrosis[J]. Sci Transl Med, 2012, 4 (136): 136ra71.
|
7 |
Nishimoto T, Mlakar L, Takihara T, et al. An endo-statin-derived peptide orally exerts anti-fibrotic activity in a murine pulmonary fibrosis model[J]. Int Immunopharmacol, 2015, 28 (2): 1102-1105.
|
8 |
Hu B, Phan SH. Notch in fibrosis and as a target of anti-fibrotic therapy[J]. Pharmacol Res, 2016 (108): 57-64.
|
9 |
Andrae J, Gallini R, Betsholtz C. Role of platelet-derived growth factors in physiology and medicine[J]. Gene Dev, 2008, 22 (10): 1276-1312.
|
10 |
Wang YC, Dong J, Nie J, et al. Amelioration of bleomycin-induced pulmonary fibrosis by chlorogenic acid through endoplasmic reticulum stress inhibition[J]. Apoptosis, 2017, 22 (9): 1147-1156.
|
11 |
Zhang K, Yang S, Zhu Y, et al. Protection against acute radiation-induced lung injury: a novel role for the anti-angiogenic agent Endostar[J]. Mol Med Rep, 2012, 6 (2): 309-315.
|
12 |
King TE Jr, Pardo A, Selman M. Idiopathic pulmonary fibrosis[J]. Lancet, 2011, 378 (9807): 1949-1961.
|
13 |
Wang Y, Liu J, Chen J, et al. MiR-29 mediates TGFβ1-induced extracellular matrix synthesis through activation of Wnt/β-catenin pathway in human pulmonary fibroblasts[J]. Technol Health Care, 2015 (23 Suppl 1): S119-S125.
|
14 |
Wang YC, Liu JS, Tang HK, et al. miR-221 targets HMGA2 to inhibit bleomycin-induced pulmonary fibrosis by regulating TGF-β1/Smad3-induced EMT[J]. Int J Mol Med, 2016, 38 (4): 1208-1216.
|
15 |
Bochaton-Piallat ML, Gabbiani G, Hinz B. The myofibroblast in wound healing and fibrosis: answered and unanswered questions[J]. F1000Res, 2016 (5. pii): F1000 Faculty Rev-752.
|
16 |
Hardie WD, Glasser SW, Hagood JS. Emerging concepts in the pathogenesis of lung fibrosis[J]. Am J Pathol, 2009, 175 (1): 3-16.
|
17 |
O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth[J]. Cell, 1997, 88 (2): 277-285.
|
18 |
Lee JH, Isayeva T, Larson MR, et al. Endostatin: a novel inhibitor of androgen receptor function in prostate cancer[J]. Proc Natl Acad Sci USA, 2015, 112 (5): 1392-1397.
|
19 |
Peng Y, Gao M, Jiang Y, et al. Angiogenesis inhibitor endostatin protects mice with sepsis from multiple organ dysfunction syndrome[J]. Shock, 2015, 44 (4): 357-364.
|
20 |
Martensson J, Jonsson N, Glassford NJ, et al. Plasma endostatin may improve acute kidney injury risk prediction in critically ill patients[J]. Ann Intensive Care, 2016, 6 (1): 6.
|
21 |
Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development[J]. Science, 1999, 284 (5415): 770-776.
|
22 |
Zhang K, Zhang YQ, Ai WB, et al. Hes1, an important gene for activation of hepatic stellate cells, is regulated by Notch1 and TGF-β/BMP signaling[J]. World J Gastroenterol, 2015, 21 (3): 878-887.
|
23 |
Jin S, Hansson EM, Tikka S, et al. Notch signaling regulates platelet-derived growth factor receptor-beta expression in vascular smooth muscle cells[J]. Circ Res, 2008, 102 (12): 1483-1491.
|
24 |
Lin X, Kong LN, Huang C, et al. Hesperetin derivative-7 inhibits PDGF-BB-induced hepatic stellate cell activation and proliferation by targeting Wnt/β-catenin pathway[J]. Int Immunopharmacol, 2015, 25 (2): 311-320.
|
25 |
Tsao PN, Matsuoka C, Wei SC, et al. Epithelial Notch signaling regulates lung alveolar morphogenesis and airway epithelial integrity[J]. Proc Natl Acad Sci USA, 2016, 113 (29): 8242-8247.
|
26 |
Tan EM, Qin H, Kennedy SH, et al. Platelet-derived growth factors-AA and -BB regulate collagen and collagenase gene expression differentially in human fibroblasts[J]. Biochem J, 1995, 310 (Pt2): 585-588.
|
27 |
Aono Y, Kishi M, Yokota Y, et al. Role of platelet-derived growth factor/platelet-derived growth factor receptor axis in the trafficking of circulating fibrocytes in pulmonary fibrosis[J]. Am J Respir Cell Mol Biol, 2014, 51 (6): 793-801.
|
28 |
Fang L, Zhan S, Huang C, et al. TRPM7 channel regulates PDGF-BB-induced proliferation of hepatic stellate cells via PI3K and ERK pathways[J]. Toxicol Appl Pharmacol, 2013, 272 (3): 713-725.
|
29 |
Richeldi L, Cottin V, du Bois RM, et al. Nintedanib in patients with idiopathic pulmonary fibrosis: combined evidence from the TOMORROW and INPULSIS(®) trials[J]. Respir Med, 2016 (113): 74-79.
|
30 |
Hung C, Linn G, Chow YH, et al. Role of lung pericytes and resident fibroblasts in the pathogenesis of pulmonary fibrosis[J]. Am J Respir Crit Care Med, 2013, 188 (7): 820-830.
|
31 |
Rock JR, Barkauskas CE, Cronce MJ, et al. Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition[J]. Proc Natl Acad Sci USA, 2011, 108 (52): E1475-E1483.
|
32 |
吴逢选,张京臣,姜久昆,等.转化生长因子β1/Smads通路在百草枯中毒所致上皮-间充质转变和肺纤维化中的作用研究[J/CD].中华危重症医学杂志(电子版),2018,11(1):3-10.
|
33 |
Bichsel CA, Hall SR, Schmid RA, et al. Primary human lung pericytes support and stabilize in vitro perfusable microvessels[J]. Tissue Eng Part A, 2015, 21 (15-16): 2166-2176.
|
34 |
Rowley JE, Johnson JR. Pericytes in chronic lung disease[J]. Int Arch Allergy Immunol, 2014, 164 (3): 178-188.
|
35 |
陈俊伊,王懿春.微小RNA-21和转化生长因子β1在急性呼吸窘迫综合征大鼠肺纤维化组织中的表达变化[J/CD].中华危重症医学杂志(电子版),2016,9(4):234-239.
|